Clinical trial
Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing…
NCT00493428 · University of Manitoba, Other · Withdrawn
Key facts
| NCT number | NCT00493428 |
|---|---|
| Title | Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study |
| Official title | Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study |
| Lead sponsor | University of Manitoba, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | Baclofen |
| Enrollment | 0 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Jun 28, 2007 |
| Last update posted | May 16, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: